Emergent Biosolutions Inc (EBS) — Strategic Asset Allocation Index
Emergent Biosolutions Inc (EBS) has a Strategic Asset Allocation Index of 41.3% as of December 2025. Strategic assets (PP&E of $216.00 Million plus long-term investments of $-) total $216.00 Million, measured against net assets of $522.60 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check EBS asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Emergent Biosolutions Inc Strategic Asset Allocation Index (2004–2025)
This chart shows how Emergent Biosolutions Inc's Strategic Asset Allocation Index has evolved across 22 annual periods from 2004 to 2025. As of December 2025, the index stands at 41.3%, representing strategic assets of $216.00 Million against net assets of $522.60 Million USD. See EBS FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Emergent Biosolutions Inc (2004–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Emergent Biosolutions Inc from 2004 to 2025, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see EBS stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 41.3% | $216.00 Million | $216.00 Million | $- | $522.60 Million | ▼ -17.1 pp |
| 2024 | 58.5% | $282.30 Million | $282.30 Million | $- | $482.80 Million | ▼ -3.0 pp |
| 2023 | 61.5% | $399.00 Million | $399.00 Million | $- | $649.30 Million | ▲ +2.5 pp |
| 2022 | 58.9% | $817.60 Million | $817.60 Million | $- | $1.39 Billion | ▲ +9.3 pp |
| 2021 | 49.6% | $800.10 Million | $800.10 Million | $- | $1.61 Billion | ▲ +5.1 pp |
| 2020 | 44.5% | $644.10 Million | $644.10 Million | $- | $1.45 Billion | ▼ -5.3 pp |
| 2019 | 49.8% | $542.30 Million | $542.30 Million | $- | $1.09 Billion | ▼ -0.6 pp |
| 2018 | 50.5% | $510.20 Million | $510.20 Million | $- | $1.01 Billion | ▲ +5.8 pp |
| 2017 | 44.6% | $407.21 Million | $407.21 Million | $- | $912.35 Million | ▼ -18.5 pp |
| 2016 | 63.1% | $376.45 Million | $376.45 Million | $- | $596.21 Million | ▲ +12.9 pp |
| 2015 | 50.3% | $331.86 Million | $331.86 Million | $- | $660.02 Million | ▼ -6.5 pp |
| 2014 | 56.8% | $313.98 Million | $313.98 Million | $- | $553.20 Million | ▲ +2.7 pp |
| 2013 | 54.0% | $264.24 Million | $264.24 Million | $- | $489.17 Million | ▼ -0.7 pp |
| 2012 | 54.7% | $241.76 Million | $241.76 Million | $- | $442.13 Million | ▲ +4.5 pp |
| 2011 | 50.1% | $208.97 Million | $208.97 Million | $- | $416.73 Million | ▲ +9.3 pp |
| 2010 | 40.9% | $152.70 Million | $152.70 Million | $- | $373.56 Million | ▼ -13.2 pp |
| 2009 | 54.1% | $131.83 Million | $131.83 Million | $- | $243.81 Million | ▼ -8.5 pp |
| 2008 | 62.5% | $124.66 Million | $124.66 Million | $- | $199.35 Million | ▼ -1.9 pp |
| 2007 | 64.4% | $110.22 Million | $110.22 Million | $- | $171.16 Million | ▲ +7.9 pp |
| 2006 | 56.5% | $78.17 Million | $78.17 Million | $- | $138.47 Million | ▲ +5.2 pp |
| 2005 | 51.3% | $30.64 Million | $30.64 Million | $- | $59.74 Million | ▼ -67.5 pp |
| 2004 | 118.8% | $27.27 Million | $27.27 Million | $- | $22.95 Million | — |